News Europe delays review of PTC's Duchenne drug Review of marketing authorisation delayed, new trial likely.
News How will Brexit affect rare disease research? The decision to leave the European Union is causing concern across all healthcare disciplines, with few answers to the many questions about where the UK will stand in relation to Europe.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
